Individualisierte Medizin bei ausgewählten Krebserkrankungen
- authored by
- Marika Plöthner, Jan Zeidler, Johann Matthias Graf Von Der Schulenburg
- Abstract
The administration of targeted therapies (TT) has improved the treatment of some oncological indications. Five substances for TT in lung cancer and 11 substances for TT in breast cancer have been approved so far. An increased survival time and better response to treatment in EGFR-positive lung cancer patients as well as an increased quality of life in breast cancer could be proven. Actually, some economic and medical challenges preclude a wider application of targeted therapies in the oncology.
- Organisation(s)
-
Center for Health Economics Research Hannover (CHERH)
- Type
- Article
- Journal
- Public Health Forum
- Volume
- 24
- Pages
- 131-134
- No. of pages
- 4
- ISSN
- 0944-5587
- Publication date
- 01.06.2016
- Publication status
- Published
- Peer reviewed
- Yes
- ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- Sustainable Development Goals
- SDG 3 - Good Health and Well-being
- Electronic version(s)
-
https://doi.org/10.1515/pubhef-2016-1004 (Access:
Closed)
